BSRR
Sierra Bancorp
BSRR's outlook is improving, though it still trails on the overall score.
MS
Morgan Stanley
MS has the edge over BSRR overall, supported by stronger modeled upside and stronger valuation.
BSRR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
BSRR's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like BSRR.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BSRR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $31.30 | -26% |
| Fair | 9.4x | $36.40 | -13% |
| Current | 11x | $42.06 | — |
| Forward | 11x | $42.06 | — |
| Expensive | 12x | $45.12 | +7.3% |
Historical ranges are pointers, not guarantees.
BSRR has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BSRR Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect BSRR's earnings to grow and its profitability to improve, with its revenue holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over BSRR on the outlook, with more favorable valuation and revenue expectations.
BSRR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.87 | -0.1% |
| Q3 2026 | $3.87 | +35% |
| Q2 2026 | $3.41 | +18% |
| Q1 2026 | $3.42 | +21% |
| Q4 2025 | $3.11 | +11% |
| Q3 2025 | $2.87 | +14% |
| Q2 2025 | $2.89 | +17% |
| Q1 2025 | $2.82 | +17% |
| Q4 2024 | $2.81 | +19% |
BSRR's earnings per share have climbed steadily: $3.87 over the past year, up 35% from the year before, and higher year over year for 13 quarters in a row.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BSRR on earnings, with stronger typical year-over-year growth.
BSRR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $40.1M | +0.1% |
| Q2 2026 | $39M | -0.6% |
| Q1 2026 | $38.6M | +5% |
| Q4 2025 | $39.3M | +3.8% |
| Q3 2025 | $40M | +3.8% |
| Q2 2025 | $39.2M | +3.7% |
| Q1 2025 | $36.8M | -1.5% |
| Q4 2024 | $37.9M | +5.4% |
BSRR's revenue grew through 2024 and has held roughly level since: $40M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 49% | +18 points |
| Q2 2026 | 34% | -2.3 points |
| Q1 2026 | 43% | +10 points |
| Q4 2025 | 44% | +10 points |
| Q3 2025 | 32% | -5.6 points |
| Q2 2025 | 36% | -1.3 points |
| Q1 2025 | 33% | -0.6 points |
| Q4 2024 | 33% | +10 points |
BSRR has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over BSRR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
BSRR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $20.7M | +41% |
| Q2 2026 | $5.4M | +$41.7M |
| Q1 2026 | $11M | -73% |
| Q4 2025 | $13.5M | -38% |
| Q3 2025 | $14.7M | -46% |
| Q2 2025 | -$36.3M | -18076% |
| Q1 2025 | $40.2M | +509% |
| Q4 2024 | $21.9M | +437% |
BSRR has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BSRR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -35.6K shares |
| 1 year | -4.1% | -547K shares |
| 3 years | -12% | -1.7M shares |
| 5 years | -16% | -2.4M shares |
| Available history | -16% | -2.5M shares |
BSRR has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $5M |
| Q1 2026 | $9.9M |
| Q4 2025 | $7.5M |
| Q3 2025 | $6M |
| Q2 2025 | $4M |
| Q1 2025 | $14.3M |
| Q4 2024 | $7.2M |
BSRR spent $22M buying back its own shares over the past year, down 29% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
BSRR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.8x | Net Cash |
| Q4 2025 | 4.7x | High |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | 1.1x | Healthy |
BSRR has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BSRR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 60.4 | Neutral |
BSRR's weekly RSI is 62 (neutral) and its Stochastic is 60 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BSRR PE vs Financial Services Sector
| Metric | BSRR | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 17% below |
| PE % | 71 | 63 | 8 pts above |
BSRR has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
BSRR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.7 | 3.4% above |
| 20 week MA | $40.8 | 3.2% above |
| 50 week MA | $37.9 | 11% above |
| 100 week MA | $33.4 | 26% above |
| 200 week MA | $27.5 | 53% above |
BSRR has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BSRR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.2 | $23.6 | -19% |
| 2021 | $23.6 | $27.3 | +16% |
| 2022 | $27.3 | $21.7 | -21% |
| 2023 | $21.7 | $22.6 | +4% |
| 2024 | $22.6 | $29.0 | +29% |
| 2025 | $29.0 | $33.1 | +14% |
| 2026 YTD | $33.1 | $42.1 | +27% |
BSRR has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.